Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Xenetic Biosciences Inc.

    NASDAQ: XBIO · Real-Time Price · USD
    2.78
    0.01 (0.36%)
    At close: Jun 20, 2025, 3:10 PM
    2.99
    7.55%
    After-hours: Jun 20, 2025, 05:06 PM EDT

    Xenetic Biosciences Statistics

    Share Statistics

    Xenetic Biosciences has 1.54M shares outstanding. The number of shares has increased by 0.09% in one year.

    Shares Outstanding

    n/a
    		 1.54M

    Shares Change (YoY)

    n/a
    		 0.09%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 3.8%

    Shares Floating

    n/a
    		 1.25M

    Failed to Deliver (FTD) Shares

    n/a
    		 7,032

    FTD / Avg. Volume

    n/a
    		 86.7%

    Short Selling Information

    The latest short interest is 3.49K, so 0.23% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 3.49K

    Short % of Shares Out

    n/a
    		 0.23%

    Short % of Float

    n/a
    		 0.24%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -1.55 and the forward PE ratio is -0.62. Xenetic Biosciences's PEG ratio is 0.3.

    PE Ratio

    n/a
    		 -1.55

    Forward PE

    n/a
    		 -0.62

    PS Ratio

    n/a
    		 2.46

    Forward PS

    n/a
    		 0.4

    PB Ratio

    n/a
    		 1.02

    P/FCF Ratio

    n/a
    		 -2.18

    PEG Ratio

    n/a
    		 0.3
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Xenetic Biosciences.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 7.37, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 7.37

    Quick Ratio

    n/a
    		 7.37

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $1,250,142

    Profits Per Employee

    n/a
    		 $-1,980,137.5

    Employee Count

    n/a
    		 2

    Asset Turnover

    n/a
    		 0.36

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -30.92% in the last 52 weeks. The beta is 2.29, so Xenetic Biosciences's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.29

    52-Week Price Change

    n/a
    		 -30.92%

    50-Day Moving Average

    n/a
    		 2.86

    200-Day Moving Average

    n/a
    		 3.65

    Relative Strength Index (RSI)

    n/a
    		 42.52

    Average Volume (20 Days)

    n/a
    		 8,111

    Income Statement

    In the last 12 months, Xenetic Biosciences had revenue of 2.5M and earned -3.96M in profits. Earnings per share was -2.57.

    Revenue

    n/a
    		 2.5M

    Gross Profit

    n/a
    		 2.5M

    Operating Income

    n/a
    		 -4.2M

    Net Income

    n/a
    		 -3.96M

    EBITDA

    n/a
    		 -4.2M

    EBIT

    n/a
    		 -4.2M

    Earnings Per Share (EPS)

    n/a
    		 -2.57
    Full Income Statement

    Balance Sheet

    The company has 6.17M in cash and 0 in debt, giving a net cash position of 6.17M.

    Cash & Cash Equivalents

    n/a
    		 6.17M

    Total Debt

    n/a
    		 n/a

    Net Cash

    n/a
    		 n/a

    Retained Earnings

    n/a
    		 -197.19M

    Total Assets

    n/a
    		 5.79M

    Working Capital

    n/a
    		 4.81M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -2.82M and capital expenditures 0, giving a free cash flow of -2.82M.

    Operating Cash Flow

    n/a
    		 -2.82M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -2.82M

    FCF Per Share

    n/a
    		 -1.83
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of -168.16% and -158.39%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 -168.16%

    Pretax Margin

    n/a
    		 -158.39%

    Profit Margin

    n/a
    		 -158.39%

    EBITDA Margin

    n/a
    		 -168.16%

    EBIT Margin

    n/a
    		 -168.16%

    FCF Margin

    n/a
    		 -112.69%

    Dividends & Yields

    XBIO does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for XBIO.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on May 15, 2023. It was a backward split with a ratio of 1:10.

    Last Split Date

    n/a
    		 May 15, 2023

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:10

    Scores

    Altman Z-Score

    n/a
    		 -44.53

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist